BridgeMD
New treatment option for Spondyloarthritis
Official title The Role of Intestinal Microbiota Dysbiosis in the Development of Spondyloarthritis
ClinicalTrials.gov ID: NCT04853212
What this study is testing
- What it's testing
- The primary objective of this case-control study aims to explore the role of bacterium Ruminococcus gnavus (R. gnavus) with intestinal biopsy and faecal sampling in the initiation and the development of spondyloarthritis (SPA) in comparison with health control subjets (patients without chronic disease but have indication to digestive endoscopy).
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- Patients with SPA:
- Patients ⩾ 18 years;
- Diagnosed as spondyloarthritis (SpA) according ASAS classification;
- Affiliated to a social security scheme;
- Have signed the written informed consent form. Control people:
You likely can't join if
- people unable to understand the proposed study and/or sign a informed consent form;
- Pregnant women or breast feeding women;
- people under guardianship or curatorship;
- Have taken antibiotic 1 month prior to inclusion;
- Presenting acute or chronic severe pathology may likely to interfere with the interpret of outcome;
- Refusal of people to participate to the study;
See the full eligibility criteria
- Patients with SPA:
- Patients ⩾ 18 years;
- Diagnosed as spondyloarthritis (SpA) according ASAS classification;
- Affiliated to a social security scheme;
- Have signed the written informed consent form. Control people:
- people ⩾ 18 years;
- people free of SPA and planned for a digestive endoscopy for another indication such as to explore the risk of colorectal cancer in family member;
- Affiliated to a social security scheme;
- Have signed the written informed consent form.
- people unable to understand the proposed study and/or sign a informed consent form;
- Pregnant women or breast feeding women;
- people under guardianship or curatorship;
- Have taken antibiotic 1 month prior to inclusion;
- Presenting acute or chronic severe pathology may likely to interfere with the interpret of outcome;
- Refusal of people to participate to the study;
- Foreign patients under french AME scheme.
The study team makes the final eligibility decision.
Where it's taking place
- Boulogne-Billancourt, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Boulogne-Billancourt, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.